[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100219822":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":19,"centralContacts":23,"locations":33,"responsibleParty":119,"collaborators":10,"id":121,"slug":122,"hasResults":123,"nctId":124,"briefTitle":125,"officialTitle":126,"acronym":10,"eligibilityCriteria":127,"healthyVolunteers":123,"sex":128,"minAge":129,"maxAge":10,"enrollmentInfo":130,"targetDuration":10,"studyType":133,"phases":10,"briefSummary":134,"conditions":135,"keywords":137,"overallStatus":36,"whyStopped":10,"lastUpdateSubmitDate":139,"lastUpdatePostDateStruct":140,"startDateStruct":143,"completionDateStruct":145,"leadSponsor":147,"locationsCount":148},{"fullName":5,"class":6},"Cliniques universitaires Saint-Luc- Université Catholique de Louvain","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"No treatment",null,"Patients with squamous cell carcinoma of the head and neck, targeted therapies, plasma samples:\n\n* Group 1 = patients treated with radiation therapy and cetuximab according to Bonner et al \\[11\\]\n* Group 2 = patients treated with cetuximab in combination with chemotherapy according to Vermorken et al. \\[10\\]\n* Group 3 = patients treated with a molecular targeted agent as a part of a clinical study",[13],"Other: Plasma samples",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"Plasma samples","Plasma samples at baseline (and one whole blood sample) and at every radiological evaluations",[9],[20],{"name":21,"affiliation":5,"role":22},"Jean-Pascal Machiels, MD, PhD","PRINCIPAL_INVESTIGATOR",[24,29],{"name":21,"role":25,"phone":26,"phoneExt":27,"email":28},"CONTACT","0032 2 764","5457","jean-pascal.machiels@uclouvain.be",{"name":30,"role":25,"phone":26,"phoneExt":31,"email":32},"Séverine Carlier, MD","47849","severine.carlier@uclouvain.be",[34,55,72,88,103],{"facility":35,"status":36,"city":37,"state":38,"zip":39,"country":40,"countryCode":41,"cosmosGeoPoint":42,"geoPoint":47,"contacts":48},"Clinique Saint-Pierre","RECRUITING","Ottignies","Brabant Wallon","1340","Belgium","BE",{"type":43,"coordinates":44},"Point",[45,46],4.56679,50.66535,{"lat":46,"lon":45},[49,52,54],{"name":50,"role":25,"phone":10,"phoneExt":10,"email":51},"Renaud Poncin, MD","Re.PONCIN@clinique-saint-pierre.be",{"name":53,"role":25,"phone":10,"phoneExt":10,"email":10},"Dora Barrientos, Nurse",{"name":50,"role":22,"phone":10,"phoneExt":10,"email":10},{"facility":56,"status":36,"city":57,"state":58,"zip":59,"country":40,"countryCode":41,"cosmosGeoPoint":60,"geoPoint":64,"contacts":65},"Grand Hôpital de Charleroi","Charleroi","Hainaut","6000",{"type":43,"coordinates":61},[62,63],4.44448,50.41136,{"lat":63,"lon":62},[66,69,71],{"name":67,"role":25,"phone":10,"phoneExt":10,"email":68},"Christophe Lonchay, MD","Christophe.Lonchay@ghdc.be;",{"name":70,"role":25,"phone":10,"phoneExt":10,"email":10},"Janique Dewelle, Bio MSc",{"name":67,"role":22,"phone":10,"phoneExt":10,"email":10},{"facility":73,"status":36,"city":74,"state":10,"zip":75,"country":40,"countryCode":41,"cosmosGeoPoint":76,"geoPoint":80,"contacts":81},"Centre Hospitalier Jolimont-Lobbes-Nivelles-Tubize","Haine-Saint-Paul","7100",{"type":43,"coordinates":77},[78,79],4.1885,50.45544,{"lat":79,"lon":78},[82,85,87],{"name":83,"role":25,"phone":10,"phoneExt":10,"email":84},"Emmanuel Seront, MD, PhD","Emmanuel.Seront@jolimont.be",{"name":86,"role":25,"phone":10,"phoneExt":10,"email":10},"Isabelle Buelens, Study Co",{"name":83,"role":22,"phone":10,"phoneExt":10,"email":10},{"facility":89,"status":36,"city":90,"state":10,"zip":91,"country":40,"countryCode":41,"cosmosGeoPoint":92,"geoPoint":96,"contacts":97},"CHU Liège","Liège","4000",{"type":43,"coordinates":93},[94,95],5.56749,50.63373,{"lat":95,"lon":94},[98,101],{"name":99,"role":25,"phone":10,"phoneExt":10,"email":100},"Maude Piron, PhD","brieuc.sautois@chuliege.be",{"name":102,"role":22,"phone":10,"phoneExt":10,"email":10},"Brieu Sautois",{"facility":104,"status":36,"city":105,"state":10,"zip":106,"country":40,"countryCode":41,"cosmosGeoPoint":107,"geoPoint":111,"contacts":112},"Clinique et Maternité Sainte-Elisabeth","Namur","5000",{"type":43,"coordinates":108},[109,110],4.86746,50.4669,{"lat":110,"lon":109},[113,116,118],{"name":114,"role":25,"phone":10,"phoneExt":10,"email":115},"Stéphanie Henry, MD","Stephanie.HENRY@cmsenamur.be",{"name":117,"role":25,"phone":10,"phoneExt":10,"email":10},"Monique Gilsoul, Study Co",{"name":114,"role":22,"phone":10,"phoneExt":10,"email":10},{"type":120,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100219822","collection-of-plasma-samples-for-squamous-cell-carcinoma-of-the-head-and-neck-patients-100219822",false,"NCT02139020","Collection of Plasma Samples for Squamous Cell Carcinoma of the Head and Neck Patients","Prospective Collection of Plasma Samples From Patients Treated With Molecular Targeted Therapies for Squamous Cell Carcinoma of the Head and Neck","Inclusion Criteria:\n\n* patients treated with radiation therapy and cetuximab according to Bonner et al\n* patients treated with cetuximab in combination with chemotherapy according to Vermorken et al.\n* patients treated with a molecular targeted agent as a part of a clinical study\n\nExclusion Criteria:\n\n* patients with another type of head and neck cancer\n* patients non treated with targeted therapies","ALL","18 Years",{"count":131,"type":132},400,"ESTIMATED","OBSERVATIONAL","The investigators will collect plasma samples at baseline, during treatment, and at progression.",[136],"Squamous Cell Carcinoma of the Head and Neck",[138,16],"Targeted therapies","2023-12-08",{"date":141,"type":142},"2023-12-11","ACTUAL",{"date":144,"type":10},"2013-02",{"date":146,"type":132},"2033-01",{"name":5,"class":6},5]